Peak Pharmaceuticals, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015
For the nine months, the company reported revenues of $751,313. Net loss was $1,893,779 against $2,492,464 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +90.48% | -11.11% | +131.21% |
1st Jan change | Capi. | |
---|---|---|
+131.21% | 83.7M | |
+8.91% | 85.92B | |
+5.14% | 77.93B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |